NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 6 percent, with increases coming from all of its reporting units.

The St. Louis-based chemicals and research products firm reported total revenues of $554 million for the three-month period ended June 30, compared to $522 million for the second quarter of 2009. Excluding the impact of currency exchange, Sigma-Aldrich's sales were up 7 percent for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.